ES533263A0 - Procedimiento para la preparacion de una vacuna neumococcica multivalente. - Google Patents

Procedimiento para la preparacion de una vacuna neumococcica multivalente.

Info

Publication number
ES533263A0
ES533263A0 ES533263A ES533263A ES533263A0 ES 533263 A0 ES533263 A0 ES 533263A0 ES 533263 A ES533263 A ES 533263A ES 533263 A ES533263 A ES 533263A ES 533263 A0 ES533263 A0 ES 533263A0
Authority
ES
Spain
Prior art keywords
procedure
preparation
pneumococcal vaccine
multivalent pneumococcal
multivalent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES533263A
Other languages
English (en)
Other versions
ES8602417A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Holdings LLC
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of ES8602417A1 publication Critical patent/ES8602417A1/es
Publication of ES533263A0 publication Critical patent/ES533263A0/es
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/831—Drug, bio-affecting and body treating compositions involving capsular polysaccharide of bacterium, e.g. polyribosyl ribitol phosphate

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
ES533263A 1984-04-12 1984-06-08 Procedimiento para la preparacion de una vacuna neumococcica multivalente. Granted ES533263A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/599,318 US4686102A (en) 1984-04-12 1984-04-12 Multivalent pneumococcal vaccine and preparation thereof

Publications (2)

Publication Number Publication Date
ES8602417A1 ES8602417A1 (es) 1985-12-16
ES533263A0 true ES533263A0 (es) 1985-12-16

Family

ID=24399151

Family Applications (1)

Application Number Title Priority Date Filing Date
ES533263A Granted ES533263A0 (es) 1984-04-12 1984-06-08 Procedimiento para la preparacion de una vacuna neumococcica multivalente.

Country Status (9)

Country Link
US (1) US4686102A (es)
EP (1) EP0157899B1 (es)
JP (1) JPH0641422B2 (es)
AT (1) AT399655B (es)
AU (1) AU569946B2 (es)
CA (1) CA1216235A (es)
DE (1) DE3485778T2 (es)
ES (1) ES533263A0 (es)
ZA (1) ZA852724B (es)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4877613A (en) * 1987-08-05 1989-10-31 Biotech Connections, Inc. Process for preparing veterinary acellular vaccines against gram-negative nonenteric pathogenic bacilli
CA2059692C (en) * 1991-01-28 2004-11-16 Peter J. Kniskern Pneumoccoccal polysaccharide conjugate vaccine
CA2059693C (en) * 1991-01-28 2003-08-19 Peter J. Kniskern Polysaccharide antigens from streptococcus pneumoniae
US5314811A (en) * 1992-07-13 1994-05-24 Merck & Co., Inc. Process for converting lipid-containing bacterial capsular polysaccharide into lipid-free polysaccharide
US5371197A (en) * 1991-09-24 1994-12-06 Merck & Co., Inc. Protein-dimeric polysaccharide conjugate vaccine
US5314822A (en) * 1992-10-15 1994-05-24 Merck & Co., Inc. Method of clonal growth of Streptococcus pneumoniae
US5565204A (en) * 1994-08-24 1996-10-15 American Cyanamid Company Pneumococcal polysaccharide-recombinant pneumolysin conjugate vaccines for immunization against pneumococcal infections
US5714354A (en) * 1995-06-06 1998-02-03 American Home Products Corporation Alcohol-free pneumococcal polysaccharide purification process
DK0897427T3 (da) * 1996-02-14 2005-02-14 Merck & Co Inc Fremgangsmåde til fældning af polysaccharid
US6410025B1 (en) 1996-02-14 2002-06-25 Merck & Co., Inc. Polysaccharide precipitation process
US6224880B1 (en) 1997-09-24 2001-05-01 Merck & Co., Inc. Immunization against Streptococcus pneumoniae using conjugated and unconjugated pneumoccocal polysaccharide vaccines
US7144989B2 (en) 2002-03-25 2006-12-05 Albert Einstein College Of Medicine Of Yeshiva University Pegylated non-hypertensive hemoglobins, methods of preparing same, and uses thereof
US6737524B2 (en) 2002-03-25 2004-05-18 Paul K. Smith Activated polyethylene glycol compounds
DE602004020459D1 (de) * 2003-02-27 2009-05-20 Glaxo Group Ltd Fondaparinux- natrium zusammenstellung von hoher reinheit
US7320874B2 (en) * 2003-07-08 2008-01-22 Aventis Pasteur Sa Assaying the teichoic acids of gram+ bacteria
EP1928418B1 (en) 2005-09-30 2011-12-21 Lipoxen Technologies Limited Liposomal vaccine compositions comprising a polysaccharide antigen and a protein adjuvant
US8808707B1 (en) 2006-05-08 2014-08-19 Wyeth Llc Pneumococcal dosing regimen
PL2436700T3 (pl) 2007-03-23 2018-12-31 Wyeth Llc Skrócony sposób oczyszczania do wytwarzania polisacharydów otoczkowych Streptococcus pneumoniae
BRPI0810211A2 (pt) 2007-04-13 2014-10-21 Univ Oklahoma Citolisina dependente de colesterol mutante purficada, composição, vacina, método para vacinar um paciente, anticorpo monoclonal, ácido nucléico, e, célula hospedeira.
AU2009335824B2 (en) 2008-12-18 2013-07-04 Wyeth Llc Method for controlling Streptococcus pneumoniae polysaccharide molecular weight using carbon
CN102257155B (zh) * 2008-12-18 2016-03-02 惠氏有限责任公司 控制肺炎链球菌血清型19a多糖分子量的方法
CA2900008C (en) 2013-02-07 2025-10-07 Children's Medical Center Corporation PROTEIN ANTIGENS THAT CONFER PROTECTION AGAINST COLONIZATION AND/OR PNEUMOCOCCAL DISEASE
US11160855B2 (en) 2014-01-21 2021-11-02 Pfizer Inc. Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
MX371453B (es) * 2014-01-21 2020-01-29 Pfizer Polisacaridos capsulares de streptococcus pneumoniae y conjugados de los mismos.
CA3206112A1 (en) * 2014-01-21 2015-07-30 Pfizer Inc. Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
EP3220937B1 (en) 2014-11-21 2024-09-04 The Board of Regents of the University of Oklahoma Pneumolysin mutants and methods of use thereof
EP3325008B1 (en) * 2015-07-21 2025-09-10 Pfizer Inc. Immunogenic compositions comprising conjugated capsular saccharide antigens, kits comprising the same and uses thereof
EP4488286A3 (en) 2016-03-31 2025-04-02 Pogona, Llc Saccharide-polypeptide conjugate compositions and methods of use thereof
WO2018144799A1 (en) 2017-02-03 2018-08-09 SCHADECK, Eva, Barbara Haemophilus influenzae saccharide-carrier conjugate compositions and uses thereof
CA3062399A1 (en) 2017-05-05 2018-11-08 Serum Institute Of India Private Limited Method for removal of impurities from bacterial capsular polysaccharide based preparations
EP3634481A4 (en) 2017-06-10 2021-07-21 Inventprise, LLC. MULTIVALENT CONJUGATE VACCINES WITH BIVALENT OR MULTIVALENT CONJUGATE POLYSACCHARIDES THAT CONFIRM ENHANCED IMMUNOGENICITY AND AVIDITY
US10729763B2 (en) 2017-06-10 2020-08-04 Inventprise, Llc Mixtures of polysaccharide-protein pegylated compounds
WO2019070994A1 (en) 2017-10-04 2019-04-11 Liffey Biotech Limited SACCHARIDE-POLYPEPTIDE CONJUGATE COMPOSITIONS AND METHODS OF USE
WO2022035816A1 (en) 2020-08-10 2022-02-17 Inventprise, Llc Multivalent pneumococcal glycoconjugate vaccines containing emerging serotype 24f
CN116693706B (zh) * 2022-02-24 2024-10-11 成都生物制品研究所有限责任公司 一种肺炎链球菌荚膜多糖的纯化方法
CN116942804A (zh) 2022-04-19 2023-10-27 上海瑞宙生物科技有限公司 多价肺炎球菌多糖结合疫苗的成分及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1115210A (en) * 1977-11-28 1981-12-29 Dennis J. Carlo Pneumococcal vaccine
US4242501A (en) * 1979-08-08 1980-12-30 American Cyanamid Company Purification of pneumococcal capsular polysaccharides
BE889979A (fr) * 1981-08-14 1982-02-15 Smith Kline Rit Procede de preparation de polysaccharides bacteriens capsulaires antigeniques purifies, produits obtenus et leur utilisation

Also Published As

Publication number Publication date
DE3485778T2 (de) 1993-01-14
DE3485778D1 (de) 1992-07-23
AU4101685A (en) 1985-10-17
ES8602417A1 (es) 1985-12-16
ZA852724B (en) 1985-11-27
ATA109085A (de) 1994-11-15
AT399655B (de) 1995-06-26
US4686102A (en) 1987-08-11
JPH0641422B2 (ja) 1994-06-01
JPS60218325A (ja) 1985-11-01
EP0157899A3 (en) 1987-09-09
EP0157899B1 (en) 1992-06-17
CA1216235A (en) 1987-01-06
EP0157899A2 (en) 1985-10-16
AU569946B2 (en) 1988-02-25

Similar Documents

Publication Publication Date Title
ES533263A0 (es) Procedimiento para la preparacion de una vacuna neumococcica multivalente.
AR229346A1 (es) Procedimiento para la preparacion de una forma galenica de medicamentos de uso oral,de liberacion programada
ES554625A0 (es) Un procedimiento para la preparacion de una composicion de silicona.
AU534274B2 (en) Multivalent pneumococcal vaccine
ES498055A0 (es) Un procedimiento para la preparacion de una piridilanilina
ES522451A0 (es) Un procedimiento para la preparacion de una urea.
ES556057A0 (es) Un procedimiento para la preparacion de una composicion liofilizada de lipidos.
ES501934A0 (es) Un procedimiento para la preparacion de una fibra de alginato.
ES490210A0 (es) Un procedimiento par la preparacion de una vacuna de la gri-pe.
ES521411A0 (es) Un procedimiento para la preparacion de una vacuna contra picornavirus.
ES525544A0 (es) Un procedimiento para la preparacion de una macrolida
MX7528E (es) Procedimiento para la preparacion de una vacuna sintetica
ES554527A0 (es) Un procedimiento para la preparacion de una composicion de silicona.
ES530081A0 (es) Un procedimiento para la preparacion de una macrolida
MX17041A (es) Procedimiento para la preparacion de benzopirano pirazoles.
ES528985A0 (es) Un procedimiento para la preparacion de una b- lactama
ES506245A0 (es) Un procedimiento para la preparacion de una composicion de glucosido de diterpeno.
ES511381A0 (es) "procedimiento para la preparacion de una poliimida hidrosoluble".
AR240017A1 (es) Procedimiento de preparacion de una composicion farmaceutica para absorcion percutanea.
ES530219A0 (es) Un procedimiento para la preparacion de una macrolida
ES551964A0 (es) Un procedimiento para la preparacion de una trans-octahidro-oxazolo 4,5-g quinolina
KR890700604A (ko) 합성 항-카리에스 백신
ES555305A0 (es) Un procedimiento para la preparacion de un colorante derivado de una antacianina.
PT87935A (pt) A process for the preparation multivalent meningococcal class 1outer-membrane protein vaccines
IT1206792B (it) Procedimento per preparare una mercaptoacilprolina.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20040925